Clinica Radiotherapy Center Cluj este autorizata pentru desfasurarea studiilor clinice cu beneficiu terapeutic in cadrul specialitatilor de Oncologie Medicala si Radioterapie conform autorizatiei 580/2017.

Nr. crt Nume studiu Cod protocol Localizare
1 Protocol Title a phase III, randomised double-blind, multicentre study to compare the efficacy, safety, pharmacokinetics and immunogenicity between SB8 and Avastin in subjects with metastatic or recurrent NSCLC Samsung SB 8 Pulmonar
2 A Randomised, Parallel, Double Blinded Study to Compare the Efficacy and Safety of FKB238 to Avastin® In 1st Line Treatment for Patients with Advanced/Recurrent Non-Squamous Non-Small Cell Lung Cancer in Combination of Paclitaxel and Carboplatin Avana FKB238-002 Pulmonar
3 A phase III open-label, multicentre trial of avelumab versus platinum doublet as a first line treatment of recurrent or stage IV PD-L1+ non small cell lung cancer EMR 100070-005 JAVELIN LUNG 300 Pulmonar
4 An Open-label, randomized Phase 3 TRIAL OF Nivolumab, or Nivolumab plus Ipilimumab, versus platinum doublet chemotherapy in Subjects with Chemotherapy-naïve stage IV or recurrent Non-Small Cell Lung Cancer CA 209-227 Pulmonar
5 A phase III randomized double-blind, placebo controlled study of alpelisib in combination with fulvestrant for men and postmenopausal women with hormone receptor positive, HER2-negative advanced breast cancer which progressed on or after aromatase inhibitor (AI) treatment CBYL 719C2301 Solar 1 Mamar
6 Studiu clinic experimental de faza III, randomizat, dublu-orb, multicentric, asupra tratamentului adjuvant cu nivolumab sau placebo la subiectii cu cancer esofagian sau cancer de jonctiune eso-gastrica rezecat CA 209-577 Eso-gastric
7 A phase III open-label, multicentre trial of maintenance therapy with avelumab versus continuation of first-line chemotherapy in subjects with unresectable, locally advanced or metastatic, adenocarcinoma of the stomach, or of the gastro-esophageal junction EMR 100070-007 JAVELIN GASTRIC 100 Eso-gastric
8 A phase 3 Randomized, double-blind, multicentre study of Adjuvant Nivolumab versus Placebo in Subjects with hight Invasive Urothelial Carcinoma CA 209-274 Urotelial
9 An open label, single arm, multicentre, safety study of Atezolizumab in locally advanced or metastatic urothelial or non-urothelial carcinoma of the urinary tract MO 29983 Urotelial
10 Nanobiotics – Studiu de faza 2/3, multicentric, randomizat pentru a compara eficacitatea NBTXR3, implantat sub forma de injectie intratumorala si activat prin radioterapie, fata de radioterapia administrate ca monoterapie la pacienti cu sarcom de tesut moale local avansat la nivelul extremitatilor si al peretelui trunchiului NBTXR 3 Sarcom
11 Peace 1 Un studiu prospective, randomizat, de faza III a tratamentului de privare de androgeni, cu sau fara radioterapie locala, cu sau fara acetat de abiraterona si prednisone la pacientii ce prezinta un cancer de prostate metastazic naiv la hormononi. Peace 1 Prostata
12 A Multinational, Phase III, Rnadomized, Double-blind, placebo-controlled efficacy and safety study of enzalutamide plus androgen deprivation therapy versus placebo plus ADT in patients with metastatic hormone sensitive prostate cancer Astellas 9785-CL-0335 Prostata
13 A phase 3 randomized, placebo-controlled double-blind study of JNJ-56021927 in combination with a GNRH Agonist versus GNRH Agonist plus placebo in subjects with high-risk localized or locally advanced prostate cancer and treated with primary radiation therapy PCR3003 Prostata

 

Nr. crt Nume studiu Cod protocol Localizare
1 An Open-label, Randomized Phase 3 Efficacy Study of ASP8273 vs Erlotinib or Gefitinibin First-Line Treatment of Patients with stage IIIB/IV Non-small Cell Lung Cancer Tumors with EGFR Activating Mutations Solar Astellas 8273-CL-0302 Pulmonar

 

Conf. Dr. Kacso Gabriel, medic primar radioterapie, medic primar oncologie medicala – gabriel.kacso@amethyst-radiotherapy.com
Dr. Iacob Catalin, medic primar radioterapie, medic specialist oncologie medicala – catalin.iacob@amethyst-radiotherapy.com
Dr. Bodale Carmen, medic specialist oncologie medicala – carmen.bodale@amethyst-radiotherapy.com
Dr. Manolescu Vlad, medic specialist oncologie medicala – vlad.manolescu@amethyst-radiotherapy.com
Dr. Ungureanu Andrei, medic specialist oncologie medicala – andrei.ungureanu@amethyst-radiotherapy.com

Clinica Amethyst Cluj

Persoana contact: Ionela Terhetea
Telefon: 0723.398.133
Adresa de email: studii.clinice@amethyst-radiotherapy.com